. Author manuscript; available in PMC: 2012 Oct 1.

Published in final edited form as: Biol Blood Marrow Transplant. 2011 Mar 1;17(10):1460–1471. doi: 10.1016/j.bbmt.2011.02.001

Table 1.

Patient and graft characteristics.

Characteristics

N	72
N (%) Male	41 (56%)
Median (range) Age	36 years (1-66)
Median (range) Weight	68 kg (7-109)
N (%) Diagnosis
Acute leukemia	37 (51%)
MDS/ CML	3 (4%)
NHL/ CLL	22 (31%)
HL	10 (14%)
N (%) Conditioning
Myeloablative	52 (72%)
Non-myeloablative	20 (28%)
N (%) Prior Autologous Transplant	14 (19%)
N (%) Recipient CMV+	39 (54%)
N (%) Recipient EBV+	63 (88%)
N (%) HLA-A,-B Antigen, -DRB1 Allele Match
6/6	5 (4%)
5/6	75 (52%)
4/6	64 (44%)
Median (range) Infused TNC × 10⁷/kg
Larger unit	2.56 (1.42-11.33)
Smaller unit	1.94 (0.91-7.09)

Abbreviations: MDS, myelodysplastic syndrome; CML, chronic myelogenous leukemia; NHL, non-Hodgkin lymphoma; CLL, chronic lymphocytic leukemia; HL, Hodgkin lymphoma; CMV, cytomegalovirus; EBV, Epstein-Barr virus; HLA, human leukocyte antigen; TNC, total nucleated cell.